Tanespimycin (17-AAG) 2-layer

Tanespimycin (17-AAG) 2-layerTanespimycin (17 AAG) is a potent HSP90 inhibitor with IC50 of 5 nM in a cell free assay, having a 100 fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells. Phase 2.

WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and EGFR(E746_A750) with IC50 of 2 nM and 2 nM

potent ATP-competitive VEGFR/PDGFR inhibitor for KDR

A unique collection of 11 inhibitors for the study of JAK/STAT Pathway Inhibitor Kit

and Wireless Connection

with IC50 of <1 nM

it is possible to use laboratory glassware of various sizes

Hydrophilic Treated

USB type A

Maximum capacity [Max]: 1000g

and informs about level deviations

Corning 384 well Black with Clear Flat Bottom Not Treated Polystyrene Microplate with Low Flange

The best  weighing